Cite

HARVARD Citation

    Shen, C. et al. (n.d.). 410 Phase I study of intratumoral NBTXR3 in combination with anti-PD-1 in patients with advanced cancers. Journal for immunotherapy of cancer. p. A435. [Online]. 
  
Back to record